Osimertinib for treating locally advanced or metastatic EGFR and T790M mutation-positive non-small cell lung cancer
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI